NU SKIN ENTERPRISES, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nu Skin Enterprises, Inc. on August 17, 2026. The report discloses a material event regarding the departure of a senior officer effective on the date of the report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
Effective August 17, 2026, Justin Keisel, Executive Vice President and President of Global Sales, began a medical leave of absence. Chayce Clark, Executive Vice President, Chief Operating Officer, and Chief Legal Officer, has been assigned to lead Mr. Keisel's organization during this period.
Outlook and Risks
Management expressed well wishes for Mr. Keisel and his family as he focuses on his health. The filing does not provide updated guidance, discuss specific risks related to the transition, or detail any unusual items or contingencies beyond the executive's leave.
Key Facts for Investors
- Justin Keisel, President of Global Sales, is on medical leave effective August 17, 2026.
- Chayce Clark (EVP, COO, and CLO) is temporarily leading the Global Sales organization.
- No financial results or forward-looking guidance are included in this specific filing.